Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 28 01 2021
accepted: 17 05 2021
entrez: 14 7 2021
pubmed: 15 7 2021
medline: 23 7 2021
Statut: epublish

Résumé

The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow for real time RT-PCR SARS-CoV-2 testing using OT-2 open-source liquid-handling robots (Opentrons, NY). We have developed a framework that includes a code template which is helpful for building different stand-alone robotic stations, capable of performing specific protocols. Such stations can be combined together to create a complex multi-stage workflow, from sample setup to real time RT-PCR. Using our open-source code, it is easy to create new stations or workflows from scratch, adapt existing templates to update the experimental protocols, or to fine-tune the code to fit specific needs. Using this framework, we developed the code for two different workflows and evaluated them using external quality assessment (EQA) samples from the European Molecular Genetics Quality Network (EMQN). The affordability of this platform makes automated SARS-CoV-2 PCR testing accessible for most laboratories and hospitals with qualified bioinformatics personnel. This platform also allows for flexibility, as it is not dependent on any specific commercial kit, and thus it can be quickly adapted to protocol changes, reagent, consumable shortages, or any other temporary material constraints.

Identifiants

pubmed: 34260637
doi: 10.1371/journal.pone.0252509
pii: PONE-D-21-03093
pmc: PMC8279358
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252509

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Biol. 2020 Apr 24;18(4):e3000730
pubmed: 32330124
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
PLoS One. 2021 Feb 16;16(2):e0246302
pubmed: 33591986
Nat Biotechnol. 2020 Aug;38(8):927-931
pubmed: 32555528
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Feb 11;:
pubmed: 33712264
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156329
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Diagnostics (Basel). 2020 Apr 05;10(4):
pubmed: 32260471

Auteurs

José Luis Villanueva-Cañas (JL)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

Eva Gonzalez-Roca (E)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Immunology Department (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

Aitor Gastaminza Unanue (A)

Independent engineer, Barcelona, Spain.

Esther Titos (E)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Biochemistry and Molecular Genetics (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain.

Miguel Julián Martínez Yoldi (MJ)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Microbiology (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

Andrea Vergara Gómez (A)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.
Department of Microbiology (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

Joan Anton Puig-Butillé (JA)

Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH